Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report

Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report

Abstract Background Perivascular epithelioid cell tumors are defined by the World Health Organization as “a collection of rare mesenchymal tumors composed of histologically and immunohistochemically distinctive perivascular epithelioid cells.” Whereas localized perivascular epithelioid cell tumor is...

Full description

Bibliographic Details
Main Authors: Ali McBride, Andrew J. Garcia, Lauren J. Sanders, Kelly Yiu, Lee D. Cranmer, Phillip H. Kuo, Matthew Kay, Andrew S. Kraft
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Journal of Medical Case Reports
Subjects:
PEComa
PD-L1
Pembrolizumab
Online Access:https://doi.org/10.1186/s13256-021-02997-x

Internet

https://doi.org/10.1186/s13256-021-02997-x

Similar Items